Stimulation by neurotensin of (3H)5 hydroxytryptamine (5HT) release from rat frontal cortex slices

Neuropeptides

Volumn 32, Issue 5, 1998, Pages 465-471

  Heaulme M ^a   Leyris, R ^a   Soubrie P ^a   Le Fur, G ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTENSIN; SEROTONIN; TETRODOTOXIN; 2 [5 (2,6 DIMETHOXYPHENYL) 1 [4 [N (3 DIMETHYLAMINOPROPYL) N METHYLCARBAMOYL] 2 ISOPROPYLPHENYL] 1H PYRAZOL 3 YLCARBONYLAMINO]ADAMANTANE 2 CARBOXYLIC ACID; 2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; ADAMANTANE; DIZOCILPINE MALEATE; DOPAMINE RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; IMIDAZOLE DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTENSIN RECEPTOR; PEPTIDE FRAGMENT; POTASSIUM; PYRAZOLE DERIVATIVE; QUINOLINE DERIVATIVE; SR 48527;

ANIMAL EXPERIMENT; ARTICLE; DEPOLARIZATION; FRONTAL CORTEX; HORMONAL REGULATION; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; SEROTONIN RELEASE; ANIMAL; CORPUS STRIATUM; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FRONTAL LOBE; HIPPOCAMPUS; IC 50; IN VITRO STUDY; PHYSIOLOGY; SECRETION; SPRAGUE DAWLEY RAT;

ANIMALIA;

ADAMANTANE; ANIMALS; CORPUS STRIATUM; DIZOCILPINE MALEATE; DOPAMINE ANTAGONISTS; DOWN-REGULATION; FRONTAL LOBE; HIPPOCAMPUS; IMIDAZOLES; INHIBITORY CONCENTRATION 50; NEUROTENSIN; PEPTIDE FRAGMENTS; POTASSIUM; PYRAZOLES; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NEUROTENSIN; SEROTONIN; TETRODOTOXIN;

EID: 0031593463     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(98)90073-7     Document Type: Article

References (42)

1. Nemeroff C B, Cain S T. Neurotensin-dopamine interaction in the CNS. Trends Pharmacol Sci 1985; 6: 201-205.
2. Quirion R. Interactions between neurotensin and dopamine in the brain: an overview. Peptides 1983; 4: 609-615.
3. Kitabgi P. Neurotensin modulates dopamine neurotransmission at several levels along brain dopaminergic pathways. Neurochem Intern 1989; 14: 111-119.
4. Jiang Z G, Pessia M, North R A. Neurotensin excitation of rat ventral tegmental neurones. J Physiol 1994; 471: 119-129.
5. Keegan K L, Woodruff G N, Pinnock R D. The pharmacology of neurotensin analogues in the rat substantia nigra, pars compacta in vitro. Eur J Pharmacol 1994; 253: 131-137
6. Nalivaiko E, Michaud J C, Soubrie P, Le Fur G. Electrophysiological evidence for putative subtypes of neurotensin receptors in guinea-pig mesencephalic dopaminergic neurones. Neuroscience 1998; (in press)
7. Faggin B M, Zubieta J K, Rezvani A H, Cubeddu L X. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate. J Pharmacol Exp Ther 1990; 252: 817-825.
8. Hétier E, Boireau A, Dubedat P, Blanchard J C. Neurotensin effects on evoked release of dopamine in slices from striatum, nucleus accumbens and prefrontal cortex in rat. Naunyn-Schmiedeberg's Arch Pharmacol 1988; 337: 13-17.
9. Markstein R, Emson P. Effect of neurotensin and its fragments neurotensin (1-6) and neurotensin (8-13) on dopamine release from cat striatum. Eur J Pharmacol 1988; 152: 147-152.
10. 14C) acetylcholine in rat nucleus accumbens. Neurochem Res 1992; 17: 1143-1146.
11. Boireau A, Miquet J M, Olivier V. Neurotensin modulates differently potassium, veratridine and 4-aminopyridine-evoked release of dopamine in rat striatal slices. Fundam Clin Pharmacol 1993; 7: 109-114.
12. Okuma Y, Fukuda Y, Osumi Y. Neurotensin potentiates the potassium-induced release of endogenous dopamine from rat striatal slices. Eur J Pharmacol 1983; 93: 27-33.
13. Cooper P, Fernstrum M, Rostad O et al. The regional distribution of somatostatin, substance P and neurotensin in human brain. Brain Res 1981; 218: 219-232.
14. Emson P C, Goedert M, Horsfield P et al. The regional distribution and chromatographic characterization of neurotensin-like immunoreactivity in the rat central nervous system. J Neurochem 1982; 38: 992-999.
15. Mai J K, Triepel J, Metz J. Neurotensin in human brain. Neuroscience 1987; 22: 499-524.
16. Petrov T, Jhamandas J, Krukof T. Characterization of peptidergic efferents from the lateral parabrachial nucleus to identified neurons in the rat dorsal raphe nucleus. J Chem Neuroanat 1992; 5: 367-373.
17. Jolas T, Aghajanian G K. Neurotensin and the serotonergic system. Prog in Neurobiol 1997; 52: 455-468.
18. Kitabgi P, Rostene W, Dussaillant M et al. Two populations of neurotensin binding sites in murine brain: discrimination by an antihistaminic levocabastine, reveals markedly different radiographic distribution. Eur J Pharmacol 1987; 140: 285-293.
19. Nicot A, Rostene W, Berod A. Neurotensin receptor expression in the rat forebrain and midbrain: a combined analysis by in situ hybridization and receptor autoradiography. J Comp Neurol 1994; 341: 407-419.
20. François-Bellan A M, Tonon M C, Lin-Tong W, Beaudet A. Association of neurotensin receptors with VIP-containing neurons and serotonin-containing axons in the suprachiasmatic nucleus of the rat. Synapse 1992; 10: 282-290.
21. Van Bockstaele E J, Biswas A, Pickel V M. Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens. Brain Res 1993; 624: 188-198.
22. Jolas T, Aghajanian G K. Neurotensin excitation of serotonergic neurons in the dorsal raphe nucleus of the rat in vitro. Eur J Neurosci 1996; 8: 153-161.
23. Drumheller A D, Gagné M A, St-Pierre S, Jolicoeur F B. Effects of neurotensin of regional brain concentrations of dopamine, serotonin and their main metabolites. Neuropeptides 1990; 15: 169-178.
24. Dilts R P, Novitzki M R, Phan T H et al. Neurotensin inhibits the activation of midbrain serotonergic neurons produced by random inescapable sound. Brain Res 1996; 742: 294-298.
25. 125I]Tyr3-neurotensin. Neuroscience 1987; 22: 525-536.
26. Audinat E, Hermel J M, Crepel F. Neurotensin-induced excitation of neurons of the rat's frontal cortex studied intracellularly in vitro. Exp Brain Res 1989; 78: 358-368.
27. 3H)dopamine release evoked by KCl versus electrical depolarization. Neuropharmacol 1997; 36: 1447-1454.
28. Kabayama Y, Kato Y, Shimatsu A et al. Stimulation by gastrinrelease peptide, neurotensin and DN1417, a novel TRH analog, of dopamine and norepinephrine release from perifused rat hypothalamic fragments in vitro. Brain Res 1986; 372: 394-399.
29. Okuma Y, Osumi Y. Neurotensin-induced release of endogenous noradrenaline from rat hypothalamic slices. Life Sci 1982; 30: 77-84.
30. Lee T F, Rezvani A H, Hepler J R, Myers R D. Neurotensin releases norepinephrine differentially from perfused hypothalamus of stated and fasted rat. Am J Physiol 1987; 252: E102-E109.
31. Torocsik A, Rakovska A, Gores T, Vizi E S. Effect of neurotensin and immunoneutralization with anti- neurotensin-serum on dopaminergic-cholinergic interaction in the striatum. Brain Res 1993; 612: 306-312.
32. Lapchak P A, Araujo D M, Quirion R, Beaudet A. Neurotensin regulation of endogenous acetylcholine release from rat striatal slices is independent of dopaminergic tone. J Neurochem 1991; 56: 651-657
33. Gully D, Canton M, Boigegrain R et al. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc Natl Acad Sci U S A 1993; 90: 65-69.
34. 11] neurotensin, a highly radioactive ligand of neurotensin receptors. J Biol Chem 1983; 258: 3476-3481.
35. Faggin B M, Cubeddu L X. Rapid desensitization of dopamine release induced by neurotensin and neurotensin fragments. J Pharmacol Exp Ther 1990; 253: 812-818.
36. De Quidt M E, Emson P C. Neurotensin facilitates dopamine release in vitro from rat striatal slices. Brain Res 1983; 274: 376-380.
37. Labbe-Jullie C, Dubuc I, Brouard A et al. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes. J Pharmacol Exp Ther 1994; 268: 328-336.
38. Gully D, Labeeuw B, Boigegrain R et al. Biochemical and Pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. J Pharmacol Exp Ther 1997; 280: 802-812.
39. Azzi M, Gully D, Heaulme M et al. Neurotensin receptor interaction with dopaminergic systems in the guinea pig brain shown by neurotensin receptor antagonists. Eur J Pharmacol 1994; 255: 167-174.
40. Sanz B, Exposito I, Mora F. Effects of neurotensin on the release of glutamic acid in the prefrontal cortex and striatum of the rat. NeuroReport 1993; 4: 1194-1196.
41. Fink K, Schmitz V, Böing C, Göthert M. Stimulation of serotonin release in the rat brain cortex by activation of ionotropic glutamate receptors and its modulation via α2-heteroreceptors. Naunyn-Schmiedeberg's Arch Pharmacol 1995; 352: 394-401.
42. Soubrie P, Reisine T D, Glowinski J. Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique. Neuroscience 1984; 13: 605-625.